ReviewAAPS PharmSciTech2025
Targeted Drug Delivery for Breast Cancer using Functionalized Liposomes: Preparation Methods, Challenges, and Clinical Translation.
Review in AAPS PharmSciTech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- [Exploration and application of nanotechnology in precision transarterial chemoembolization for hepatocellular carcinoma].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026Review
- Advances in Drug Delivery Systems for Breast Cancer: From Microenvironment Barriers and Smart Carriers to Clinical Translation Strategies.Drug design, development and therapy · 2026Review
- Smart Vesicle Therapeutics: Engineering Precision at the Nanoscale.Pharmaceutics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer continues to be a major cause to cancer-related deaths globally, highlighting the urgent need for more targeted and efficient treatment approaches. This review focuses on targeted drug delivery systems using functionalized liposomes, which have emerged as promising nanocarriers due to their ability to improve drug solubility, stability, and site-specific delivery. They alter a drug's pharmacokinetics and biodistribution to improve pharmacological efficacy while minimizing systemic toxicity. The review provides a comprehensive overview of various liposome preparation methods, highlighting their advantages, limitations, and suitability for drug encapsulation. We also discuss surface modifications for active tumor targeting and overcoming challenges in the tumor microenvironment. Clinical translation hurdles, including scalability, reproducibility, and regulatory concerns, are also examined. This review concludes with an overview of current advancements and future perspectives on optimizing functionalized liposomes for personalized breast cancer therapy. The insights aim to guide the design of more effective liposomal formulations for clinical use.
Indexed as
Identifiers
40764411What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.